Back
Arcutis Biotherapeutics, Inc. (ARQT)
BiotechnologyARQT · NASDAQ NMS - GLOBAL MARKET · USD
New to investing? How to read this page →$28.78
+0.98%Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for education and research only — not financial advice.
Key metrics
EPS
$-0.13
ROE
-1.4%
Gross margin
90.9%
Debt/Equity
0.60x
Revenue growth
60.1%
Arcutis Biotherapeutics, Inc. — company intelligence
Earnings surprises
Q1 2026$-0.09 vs $-0.08 est-7.4%
Q4 2025$0.13 vs $0.12 est+12.4%
Q3 2025$0.06 vs $-0.10 est+158.9%
Q2 2025$-0.13 vs $-0.16 est+19.4%
Insider activity · 90 days
16 buys8 sellsnet +158,306 shares
Welgus Howard G.Buy 16,667 · Jun 5, 2026
Krishnamohan NehaBuy 16,667 · Jun 5, 2026
Leonard Keith RBuy 5,778 · Jun 5, 2026
Recent SEC filings
4 — Insider transaction reportJun 17, 2026
4 — Insider transaction reportJun 17, 2026
4 — Insider transaction reportJun 9, 2026
Latest news
FDA Accepts Supplemental New Drug Application For Arcutis Biotherapeutics' ZORYVE Cream 0.05% — Benzinga · 3d ago
Reported Earlier, Arcutis Expands ZORYVE Label With FDA Approval For Once-Daily Steroid-Free Plaque Psoriasis Treatment In Young Children — Benzinga · 1w ago
Arcutis Biotherapeutics Inc (NASDAQ:ARQT): A GARP Growth Play at a Reasonable Price — ChartMill · 2w ago
Is Arcutis (ARQT) Using Genital Psoriasis Education to Quietly Reshape Its Dermatology Strategy? — Yahoo · 4w ago
Arcutis Biotherapeutics Touts ZORYVE Growth, FDA Catalysts and Cash-Flow Positive Status — Yahoo · Jun 10, 2026
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
About Arcutis Biotherapeutics, Inc.
Weekly undervalued picks (like ARQT)
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.